Global Respiratory Pathogen Testing Market Size study, by Diseases (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Diseases, Others), by End-Use (Hospital Clinical Laboratories, Reference Laboratories, Physician Offices, Others) and Regi

Global Respiratory Pathogen Testing Market Size study, by Diseases (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Diseases, Others), by End-Use (Hospital Clinical Laboratories, Reference Laboratories, Physician Offices, Others) and Regional Forecasts 2022-2028

Global Respiratory Pathogen Testing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.00% over the forecast period 2022-2028. A respiratory pathogens (RP) panel examines the respiratory tract for pathogens. A pathogen is a disease-causing virus, bacterium, or another organism. The respiratory tract is made up of bodily components that help you breathe. Your lungs, nose, and throat are all affected. The increasing investments for respiratory diagnostics and rise in air pollution have led to the adoption of Respiratory Pathogen Testing across the forecast period. For Instance: on December 19, 2019, The National Institute of Allergy and Infectious Diseases (NIAID) announced the establishment of the Infectious Diseases Clinical Research Consortium. NIAID has decided to fund the Vaccine and Treatment Evaluation Units (VTEUs) program (approximately US$ 29 million per year) for seven years. Also, with the growing demand for home care and point-of-care diagnostic devices, high growth potential in developing Asia-Pacific countries, the adoption & demand for Respiratory Pathogen Testing is likely to increase the market growth during the forecast period. However, large underdiagnosed and undertreated population and lack of awareness impede the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Respiratory Pathogen Testing market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the rising prevalence of respiratory diseases. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as numerous local players engaging in the manufacturing of respiratory pathogen testing kits would create lucrative growth prospects for the Respiratory Pathogen Testing market across Asia-Pacific region.

Major market players included in this report are:
Thermo Fisher Scientific Inc. (U.S.)
Abbott Laboratories
Danaher Corporation
Becton, Dickinson and Company
Hoffmann-La Roche Ltd.
bioMérieux Inc.
Altona Diagnostics
MyLab
Philips Healthcare (Netherlands)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diseases:
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Diseases
Others
By End-Use:
Hospital Clinical Laboratories
Reference laboratories
Physician Offices
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Respiratory Pathogen Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Thermo Fisher Scientific Inc. (U.S.)
Abbott Laboratories
Danaher Corporation
Becton, Dickinson and Company
Hoffmann-La Roche Ltd.
bioMérieux Inc.
Altona Diagnostics
MyLab
Philips Healthcare (Netherlands)

Please note:The single user license is non-downloadable and non-printable. Global Site license will allow these actions.